Akorn (AKRX) : Traders are bullish on Akorn (AKRX) as it has outperformed the S&P 500 by a wide margin of 12.26% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 5.13%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 5.06% in the last 1 week, and is up 16.03% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 9.61% and the 50-Day Moving Average is 12.66%. Akorn, Inc. is up 34.5% in the last 3-month period. Year-to-Date the stock performance stands at -8.26%.
Akorn (NASDAQ:AKRX): stock turned positive on Friday. Though the stock opened at $34.11, the bulls momentum made the stock top out at $34.31 level for the day. The stock recorded a low of $33.21 and closed the trading day at $34.23, in the green by 0.32%. The total traded volume for the day was 1,277,966. The stock had closed at $34.12 in the previous days trading.
Akorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.